Skin rash composition after checkpoint inhibitor therapy varies by therapeutic regimen

Published: 5 May 2022| Version 1 | DOI: 10.17632/hw4j2k8xt3.1
Contributors:
Cory Kosche, Dinesh Jaishankar, Cormac Cosgrove, Prathyaya Ramesh, Suyeon Hong, Lin Li, Rohan Shivde, Deven Bhuva, Bethany Perez White, Sabah Munir, Hui Zhang, Jennifer Choi, I. Caroline Le Poole

Description

Patient skin rash and control cell counts.

Files

Steps to reproduce

Obtain human patient control and rash skin. Section and fix tissues appropriately. Conduct immunoenzymatic or immunofluorescent stainings, calculate area, and use microscopy to evaluate and quantify.

Institutions

Northwestern University - Chicago

Categories

Immunotherapy, T Cell, Skin Rash, Immune Checkpoint Inhibitor

Licence